Index by author
November 01, 1992; Volume 20,Issue 6
A
Abbott, F S
- You have accessCharacterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS.A E Mutlib, Y C Chui, L M Young and F S AbbottDrug Metabolism and Disposition November 1992, 20 (6) 840-848;
al-Tayib, Y
- You have accessRole of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials.C Beedham, Y al-Tayib and J A SmithDrug Metabolism and Disposition November 1992, 20 (6) 889-895;
Arison, B H
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
B
Balani, S K
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Baldeck, J P
- You have accessCyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.A E Vickers, V Fischer, S Connors, R L Fisher, J P Baldeck, G Maurer and K BrendelDrug Metabolism and Disposition November 1992, 20 (6) 802-809;
Barzago, M M
- You have accessPharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis.M Corada, A Bortolotti, M M Barzago, A Celardo, M Bonati and A GuaitaniDrug Metabolism and Disposition November 1992, 20 (6) 826-831;
Beedham, C
- You have accessRole of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials.C Beedham, Y al-Tayib and J A SmithDrug Metabolism and Disposition November 1992, 20 (6) 889-895;
Benoit, E
- You have accessSpecific and enantioselective sulfoxidation of an aryl-trifluoromethyl sulfide by rat liver cytochromes P-450.E Benoit, T Cresteil, J L Riviere and P DelatourDrug Metabolism and Disposition November 1992, 20 (6) 877-881;
Boger, R S
- You have accessSimultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.S K Gupta, G R Granneman, R S Boger, N K Hollenberg and R R LutherDrug Metabolism and Disposition November 1992, 20 (6) 821-825;
Bonati, M
- You have accessPharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis.M Corada, A Bortolotti, M M Barzago, A Celardo, M Bonati and A GuaitaniDrug Metabolism and Disposition November 1992, 20 (6) 826-831;
Bortolotti, A
- You have accessPharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis.M Corada, A Bortolotti, M M Barzago, A Celardo, M Bonati and A GuaitaniDrug Metabolism and Disposition November 1992, 20 (6) 826-831;
Boyer, C S
- You have accessPharmacokinetic analysis of the metabolism of cocaine to norcocaine and N-hydroxynorcocaine in mice.C S Boyer and D R PetersenDrug Metabolism and Disposition November 1992, 20 (6) 863-868;
Brendel, K
- You have accessCyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.A E Vickers, V Fischer, S Connors, R L Fisher, J P Baldeck, G Maurer and K BrendelDrug Metabolism and Disposition November 1992, 20 (6) 802-809;
Brewer, C F
- You have accessSubstrates for microsomal azoreductase. Hammett substituent effects, NMR studies, and response to inhibitors.S Zbaida, C F Brewer and W G LevineDrug Metabolism and Disposition November 1992, 20 (6) 902-908;
Brouwer, K L
- You have accessPharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.M J Liu, K L Brouwer and G M PollackDrug Metabolism and Disposition November 1992, 20 (6) 810-815;
Brown, N S
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
Brown, T J
- You have accessMetabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs.L A Shipley, T J Brown, J D Cornpropst, M Hamilton, W D Daniels and H W CulpDrug Metabolism and Disposition November 1992, 20 (6) 849-855;
C
Celardo, A
- You have accessPharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis.M Corada, A Bortolotti, M M Barzago, A Celardo, M Bonati and A GuaitaniDrug Metabolism and Disposition November 1992, 20 (6) 826-831;
Chandrasurin, P
- You have accessDisposition and metabolism of triprolidine in mice.D L Deal, P Chandrasurin, J Shockcor, D J Minick, J W Findlay and M J McNultyDrug Metabolism and Disposition November 1992, 20 (6) 920-927;
- You have accessDisposition of triprolidine in the male beagle dog.M J McNulty, D L Deal, T L Page, P Chandrasurin and J W FindlayDrug Metabolism and Disposition November 1992, 20 (6) 928-935;
Chang, D
- You have accessDisposition of the human immunodeficiency virus Tat inhibitor, Ro 5-3335, in rats and dogs.C Town, D Chang, L Henderson and W A GarlandDrug Metabolism and Disposition November 1992, 20 (6) 954-957;
Chui, Y C
- You have accessCharacterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS.A E Mutlib, Y C Chui, L M Young and F S AbbottDrug Metabolism and Disposition November 1992, 20 (6) 840-848;
- You have accessInvestigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.G K Poon, Y C Chui, M Jarman, M G Rowlands, P S Kokkonen, W M Niessen and J van der GreefDrug Metabolism and Disposition November 1992, 20 (6) 941-947;
Coffman, B
- You have accessStudies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes.P B Styczynski, M D Green, B Coffman and T R TephlyDrug Metabolism and Disposition November 1992, 20 (6) 896-901;
Connors, S
- You have accessCyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.A E Vickers, V Fischer, S Connors, R L Fisher, J P Baldeck, G Maurer and K BrendelDrug Metabolism and Disposition November 1992, 20 (6) 802-809;
Cook, C E
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
Coon, M J
- You have accessInduction of P-450 cytochromes 2E2, 1A1, and 1A2 by imidazole in neonatal rabbits.X Ding, H M Peng, S J Pernecky, C J Davis and M J CoonDrug Metabolism and Disposition November 1992, 20 (6) 792-796;
Corada, M
- You have accessPharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis.M Corada, A Bortolotti, M M Barzago, A Celardo, M Bonati and A GuaitaniDrug Metabolism and Disposition November 1992, 20 (6) 826-831;
Corcos, L
- You have accessPhenobarbital and dexamethasone induce expression of cytochrome P-450 genes from subfamilies IIB, IIC, and IIIA in mouse liver.L CorcosDrug Metabolism and Disposition November 1992, 20 (6) 797-801;
Cornpropst, J D
- You have accessMetabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs.L A Shipley, T J Brown, J D Cornpropst, M Hamilton, W D Daniels and H W CulpDrug Metabolism and Disposition November 1992, 20 (6) 849-855;
Covington, W P
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
Cresteil, T
- You have accessSpecific and enantioselective sulfoxidation of an aryl-trifluoromethyl sulfide by rat liver cytochromes P-450.E Benoit, T Cresteil, J L Riviere and P DelatourDrug Metabolism and Disposition November 1992, 20 (6) 877-881;
Culp, H W
- You have accessMetabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs.L A Shipley, T J Brown, J D Cornpropst, M Hamilton, W D Daniels and H W CulpDrug Metabolism and Disposition November 1992, 20 (6) 849-855;
D
Daniels, W D
- You have accessMetabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs.L A Shipley, T J Brown, J D Cornpropst, M Hamilton, W D Daniels and H W CulpDrug Metabolism and Disposition November 1992, 20 (6) 849-855;
Davis, C J
- You have accessInduction of P-450 cytochromes 2E2, 1A1, and 1A2 by imidazole in neonatal rabbits.X Ding, H M Peng, S J Pernecky, C J Davis and M J CoonDrug Metabolism and Disposition November 1992, 20 (6) 792-796;
Davis, P J
- You have accessMicrobial models of mammalian metabolism. N-dealkylation of furosemide to yield the mammalian metabolite CSA using Cunninghamella elegans.M Hezari and P J DavisDrug Metabolism and Disposition November 1992, 20 (6) 882-888;
Deal, D L
- You have accessDisposition and metabolism of triprolidine in mice.D L Deal, P Chandrasurin, J Shockcor, D J Minick, J W Findlay and M J McNultyDrug Metabolism and Disposition November 1992, 20 (6) 920-927;
- You have accessDisposition of triprolidine in the male beagle dog.M J McNulty, D L Deal, T L Page, P Chandrasurin and J W FindlayDrug Metabolism and Disposition November 1992, 20 (6) 928-935;
Delatour, P
- You have accessSpecific and enantioselective sulfoxidation of an aryl-trifluoromethyl sulfide by rat liver cytochromes P-450.E Benoit, T Cresteil, J L Riviere and P DelatourDrug Metabolism and Disposition November 1992, 20 (6) 877-881;
Ding, X
- You have accessInduction of P-450 cytochromes 2E2, 1A1, and 1A2 by imidazole in neonatal rabbits.X Ding, H M Peng, S J Pernecky, C J Davis and M J CoonDrug Metabolism and Disposition November 1992, 20 (6) 792-796;
E
Eddy, A C
- You have accessStereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.A J Sadeque, A C Eddy, G P Meier and A E RettieDrug Metabolism and Disposition November 1992, 20 (6) 832-839;
Ehlhardt, W J
- You have accessFormation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.W J Ehlhardt, J L Zimmermann, J E Ray and J E TothDrug Metabolism and Disposition November 1992, 20 (6) 958-961;
F
Findlay, J W
- You have accessDisposition and metabolism of triprolidine in mice.D L Deal, P Chandrasurin, J Shockcor, D J Minick, J W Findlay and M J McNultyDrug Metabolism and Disposition November 1992, 20 (6) 920-927;
- You have accessDisposition of triprolidine in the male beagle dog.M J McNulty, D L Deal, T L Page, P Chandrasurin and J W FindlayDrug Metabolism and Disposition November 1992, 20 (6) 928-935;
Fischer, V
- You have accessCyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.A E Vickers, V Fischer, S Connors, R L Fisher, J P Baldeck, G Maurer and K BrendelDrug Metabolism and Disposition November 1992, 20 (6) 802-809;
Fisher, R L
- You have accessCyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.A E Vickers, V Fischer, S Connors, R L Fisher, J P Baldeck, G Maurer and K BrendelDrug Metabolism and Disposition November 1992, 20 (6) 802-809;
G
Garland, W A
- You have accessDisposition of the human immunodeficiency virus Tat inhibitor, Ro 5-3335, in rats and dogs.C Town, D Chang, L Henderson and W A GarlandDrug Metabolism and Disposition November 1992, 20 (6) 954-957;
Gibson, G G
- You have accessPeroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.D E Moody, G G Gibson, D F Grant, J Magdalou and M S RaoDrug Metabolism and Disposition November 1992, 20 (6) 779-791;
Goldman, M E
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Granneman, G R
- You have accessSimultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.S K Gupta, G R Granneman, R S Boger, N K Hollenberg and R R LutherDrug Metabolism and Disposition November 1992, 20 (6) 821-825;
Grant, D F
- You have accessPeroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.D E Moody, G G Gibson, D F Grant, J Magdalou and M S RaoDrug Metabolism and Disposition November 1992, 20 (6) 779-791;
Green, M D
- You have accessStudies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes.P B Styczynski, M D Green, B Coffman and T R TephlyDrug Metabolism and Disposition November 1992, 20 (6) 896-901;
Guaitani, A
- You have accessPharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis.M Corada, A Bortolotti, M M Barzago, A Celardo, M Bonati and A GuaitaniDrug Metabolism and Disposition November 1992, 20 (6) 826-831;
Gupta, S K
- You have accessSimultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.S K Gupta, G R Granneman, R S Boger, N K Hollenberg and R R LutherDrug Metabolism and Disposition November 1992, 20 (6) 821-825;
H
Haggard, K
- You have accessOxidation of aldose reductase inhibitors ALO-4114 and ALO-3152 catalyzed by liver microsomes.A D Kiss, K Haggard, J C Veltman and D M ZieglerDrug Metabolism and Disposition November 1992, 20 (6) 948-953;
Hamilton, M
- You have accessMetabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs.L A Shipley, T J Brown, J D Cornpropst, M Hamilton, W D Daniels and H W CulpDrug Metabolism and Disposition November 1992, 20 (6) 849-855;
Hashizaki, M
- You have accessMetabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition November 1992, 20 (6) 816-820;
Henderson, L
- You have accessDisposition of the human immunodeficiency virus Tat inhibitor, Ro 5-3335, in rats and dogs.C Town, D Chang, L Henderson and W A GarlandDrug Metabolism and Disposition November 1992, 20 (6) 954-957;
Hezari, M
- You have accessMicrobial models of mammalian metabolism. N-dealkylation of furosemide to yield the mammalian metabolite CSA using Cunninghamella elegans.M Hezari and P J DavisDrug Metabolism and Disposition November 1992, 20 (6) 882-888;
Hill, J M
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
Ho, D H
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
Hoffman, J M
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Hollenberg, N K
- You have accessSimultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.S K Gupta, G R Granneman, R S Boger, N K Hollenberg and R R LutherDrug Metabolism and Disposition November 1992, 20 (6) 821-825;
J
Jarman, M
- You have accessInvestigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.G K Poon, Y C Chui, M Jarman, M G Rowlands, P S Kokkonen, W M Niessen and J van der GreefDrug Metabolism and Disposition November 1992, 20 (6) 941-947;
Jeffcoat, A R
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
K
Kauffman, L R
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
King, J D
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Kiss, A D
- You have accessOxidation of aldose reductase inhibitors ALO-4114 and ALO-3152 catalyzed by liver microsomes.A D Kiss, K Haggard, J C Veltman and D M ZieglerDrug Metabolism and Disposition November 1992, 20 (6) 948-953;
Kokkonen, P S
- You have accessInvestigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.G K Poon, Y C Chui, M Jarman, M G Rowlands, P S Kokkonen, W M Niessen and J van der GreefDrug Metabolism and Disposition November 1992, 20 (6) 941-947;
Krakoff, I H
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
Krishna, D R
- You have accessPharmacokinetics of D(+)-usnic acid in rabbits after intravenous and oral administration.D R Krishna and D VenkataramanaDrug Metabolism and Disposition November 1992, 20 (6) 909-911;
Kuritani, J
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
L
Levine, W G
- You have accessSubstrates for microsomal azoreductase. Hammett substituent effects, NMR studies, and response to inhibitors.S Zbaida, C F Brewer and W G LevineDrug Metabolism and Disposition November 1992, 20 (6) 902-908;
Liu, M J
- You have accessPharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.M J Liu, K L Brouwer and G M PollackDrug Metabolism and Disposition November 1992, 20 (6) 810-815;
Luther, R R
- You have accessSimultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.S K Gupta, G R Granneman, R S Boger, N K Hollenberg and R R LutherDrug Metabolism and Disposition November 1992, 20 (6) 821-825;
M
Magdalou, J
- You have accessPeroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.D E Moody, G G Gibson, D F Grant, J Magdalou and M S RaoDrug Metabolism and Disposition November 1992, 20 (6) 779-791;
Maurer, G
- You have accessCyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.A E Vickers, V Fischer, S Connors, R L Fisher, J P Baldeck, G Maurer and K BrendelDrug Metabolism and Disposition November 1992, 20 (6) 802-809;
McNulty, M J
- You have accessDisposition and metabolism of triprolidine in mice.D L Deal, P Chandrasurin, J Shockcor, D J Minick, J W Findlay and M J McNultyDrug Metabolism and Disposition November 1992, 20 (6) 920-927;
- You have accessDisposition of triprolidine in the male beagle dog.M J McNulty, D L Deal, T L Page, P Chandrasurin and J W FindlayDrug Metabolism and Disposition November 1992, 20 (6) 928-935;
Meier, G P
- You have accessStereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.A J Sadeque, A C Eddy, G P Meier and A E RettieDrug Metabolism and Disposition November 1992, 20 (6) 832-839;
Minick, D J
- You have accessDisposition and metabolism of triprolidine in mice.D L Deal, P Chandrasurin, J Shockcor, D J Minick, J W Findlay and M J McNultyDrug Metabolism and Disposition November 1992, 20 (6) 920-927;
Mizutani, T
- You have accessMetabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition November 1992, 20 (6) 816-820;
Moody, D E
- You have accessPeroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.D E Moody, G G Gibson, D F Grant, J Magdalou and M S RaoDrug Metabolism and Disposition November 1992, 20 (6) 779-791;
Mutlib, A E
- You have accessCharacterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS.A E Mutlib, Y C Chui, L M Young and F S AbbottDrug Metabolism and Disposition November 1992, 20 (6) 840-848;
N
Newman, R A
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
Niessen, W M
- You have accessInvestigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.G K Poon, Y C Chui, M Jarman, M G Rowlands, P S Kokkonen, W M Niessen and J van der GreefDrug Metabolism and Disposition November 1992, 20 (6) 941-947;
O
O'Brien, J A
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
P
Page, T L
- You have accessDisposition of triprolidine in the male beagle dog.M J McNulty, D L Deal, T L Page, P Chandrasurin and J W FindlayDrug Metabolism and Disposition November 1992, 20 (6) 928-935;
Patanella, J E
- You have accessOxidation of carbovir, a carbocyclic nucleoside, by rat liver cytosolic enzymes. Enantioselectivity and enantiomeric inhibition.J E Patanella and J S WalshDrug Metabolism and Disposition November 1992, 20 (6) 912-919;
Pazdur, R
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
Peng, H M
- You have accessInduction of P-450 cytochromes 2E2, 1A1, and 1A2 by imidazole in neonatal rabbits.X Ding, H M Peng, S J Pernecky, C J Davis and M J CoonDrug Metabolism and Disposition November 1992, 20 (6) 792-796;
Perez-Reyes, M
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
Pernecky, S J
- You have accessInduction of P-450 cytochromes 2E2, 1A1, and 1A2 by imidazole in neonatal rabbits.X Ding, H M Peng, S J Pernecky, C J Davis and M J CoonDrug Metabolism and Disposition November 1992, 20 (6) 792-796;
Petersen, D R
- You have accessPharmacokinetic analysis of the metabolism of cocaine to norcocaine and N-hydroxynorcocaine in mice.C S Boyer and D R PetersenDrug Metabolism and Disposition November 1992, 20 (6) 863-868;
Pitzenberger, S M
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Pollack, G M
- You have accessPharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.M J Liu, K L Brouwer and G M PollackDrug Metabolism and Disposition November 1992, 20 (6) 810-815;
Poon, G K
- You have accessInvestigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.G K Poon, Y C Chui, M Jarman, M G Rowlands, P S Kokkonen, W M Niessen and J van der GreefDrug Metabolism and Disposition November 1992, 20 (6) 941-947;
Pugh, D E
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
R
Raber, M N
- You have accessClinical pharmacology of combined oral uracil and ftorafur.D H Ho, W P Covington, R Pazdur, N S Brown, J Kuritani, R A Newman, M N Raber and I H KrakoffDrug Metabolism and Disposition November 1992, 20 (6) 936-940;
Ramjit, H G
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Rao, M S
- You have accessPeroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.D E Moody, G G Gibson, D F Grant, J Magdalou and M S RaoDrug Metabolism and Disposition November 1992, 20 (6) 779-791;
Ray, J E
- You have accessFormation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.W J Ehlhardt, J L Zimmermann, J E Ray and J E TothDrug Metabolism and Disposition November 1992, 20 (6) 958-961;
Rettie, A E
- You have accessStereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.A J Sadeque, A C Eddy, G P Meier and A E RettieDrug Metabolism and Disposition November 1992, 20 (6) 832-839;
Riviere, J L
- You have accessSpecific and enantioselective sulfoxidation of an aryl-trifluoromethyl sulfide by rat liver cytochromes P-450.E Benoit, T Cresteil, J L Riviere and P DelatourDrug Metabolism and Disposition November 1992, 20 (6) 877-881;
Rodriguez, R J
- You have accessCovalent binding of etodolac acyl glucuronide to albumin in vitro.P C Smith, W Q Song and R J RodriguezDrug Metabolism and Disposition November 1992, 20 (6) 962-965;
Rooney, C S
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Rowlands, M G
- You have accessInvestigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.G K Poon, Y C Chui, M Jarman, M G Rowlands, P S Kokkonen, W M Niessen and J van der GreefDrug Metabolism and Disposition November 1992, 20 (6) 941-947;
S
Sadeque, A J
- You have accessStereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.A J Sadeque, A C Eddy, G P Meier and A E RettieDrug Metabolism and Disposition November 1992, 20 (6) 832-839;
Sadler, B M
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
Shipley, L A
- You have accessMetabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs.L A Shipley, T J Brown, J D Cornpropst, M Hamilton, W D Daniels and H W CulpDrug Metabolism and Disposition November 1992, 20 (6) 849-855;
Shockcor, J
- You have accessDisposition and metabolism of triprolidine in mice.D L Deal, P Chandrasurin, J Shockcor, D J Minick, J W Findlay and M J McNultyDrug Metabolism and Disposition November 1992, 20 (6) 920-927;
Smith, J A
- You have accessRole of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials.C Beedham, Y al-Tayib and J A SmithDrug Metabolism and Disposition November 1992, 20 (6) 889-895;
Smith, P C
- You have accessCovalent binding of etodolac acyl glucuronide to albumin in vitro.P C Smith, W Q Song and R J RodriguezDrug Metabolism and Disposition November 1992, 20 (6) 962-965;
Song, W Q
- You have accessCovalent binding of etodolac acyl glucuronide to albumin in vitro.P C Smith, W Q Song and R J RodriguezDrug Metabolism and Disposition November 1992, 20 (6) 962-965;
Styczynski, P B
- You have accessStudies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes.P B Styczynski, M D Green, B Coffman and T R TephlyDrug Metabolism and Disposition November 1992, 20 (6) 896-901;
T
Tajima, K
- You have accessMetabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition November 1992, 20 (6) 816-820;
Tephly, T R
- You have accessStudies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes.P B Styczynski, M D Green, B Coffman and T R TephlyDrug Metabolism and Disposition November 1992, 20 (6) 896-901;
Toth, J E
- You have accessFormation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.W J Ehlhardt, J L Zimmermann, J E Ray and J E TothDrug Metabolism and Disposition November 1992, 20 (6) 958-961;
Town, C
- You have accessDisposition of the human immunodeficiency virus Tat inhibitor, Ro 5-3335, in rats and dogs.C Town, D Chang, L Henderson and W A GarlandDrug Metabolism and Disposition November 1992, 20 (6) 954-957;
V
van der Greef, J
- You have accessInvestigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.G K Poon, Y C Chui, M Jarman, M G Rowlands, P S Kokkonen, W M Niessen and J van der GreefDrug Metabolism and Disposition November 1992, 20 (6) 941-947;
Veltman, J C
- You have accessOxidation of aldose reductase inhibitors ALO-4114 and ALO-3152 catalyzed by liver microsomes.A D Kiss, K Haggard, J C Veltman and D M ZieglerDrug Metabolism and Disposition November 1992, 20 (6) 948-953;
Venkataramana, D
- You have accessPharmacokinetics of D(+)-usnic acid in rabbits after intravenous and oral administration.D R Krishna and D VenkataramanaDrug Metabolism and Disposition November 1992, 20 (6) 909-911;
Vickers, A E
- You have accessCyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.A E Vickers, V Fischer, S Connors, R L Fisher, J P Baldeck, G Maurer and K BrendelDrug Metabolism and Disposition November 1992, 20 (6) 802-809;
Voyksner, R D
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
W
Walsh, J S
- You have accessOxidation of carbovir, a carbocyclic nucleoside, by rat liver cytosolic enzymes. Enantioselectivity and enantiomeric inhibition.J E Patanella and J S WalshDrug Metabolism and Disposition November 1992, 20 (6) 912-919;
White, W R
- You have accessPharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.C E Cook, A R Jeffcoat, B M Sadler, J M Hill, R D Voyksner, D E Pugh, W R White and M Perez-ReyesDrug Metabolism and Disposition November 1992, 20 (6) 856-862;
Y
Yamamoto, K
- You have accessMetabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition November 1992, 20 (6) 816-820;
Young, L M
- You have accessCharacterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS.A E Mutlib, Y C Chui, L M Young and F S AbbottDrug Metabolism and Disposition November 1992, 20 (6) 840-848;
Z
Zbaida, S
- You have accessSubstrates for microsomal azoreductase. Hammett substituent effects, NMR studies, and response to inhibitors.S Zbaida, C F Brewer and W G LevineDrug Metabolism and Disposition November 1992, 20 (6) 902-908;
Ziegler, D M
- You have accessOxidation of aldose reductase inhibitors ALO-4114 and ALO-3152 catalyzed by liver microsomes.A D Kiss, K Haggard, J C Veltman and D M ZieglerDrug Metabolism and Disposition November 1992, 20 (6) 948-953;
Zimmermann, J L
- You have accessFormation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.W J Ehlhardt, J L Zimmermann, J E Ray and J E TothDrug Metabolism and Disposition November 1992, 20 (6) 958-961;
In this issue

Advertisement